Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Angelini

Showing results (301-310 of 531) with videos related to

Pageof 54
Sort By:
Neuromuscular Disorders : NMD|November 28, 2012
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseasesM Mancuso, C Angelini, E Bertini, et al.
Neurology|August 24, 2005
Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive conditionL Salviati, S Sacconi, L Murer, et al.
Journal of Neurology|July 2, 2010
Right hemisphere dysfunction and emotional processing in ALS: an fMRI studyA Palmieri, M Naccarato, S Abrahams, et al.
Neurology|April 12, 2003
Cerebellar ataxia and coenzyme Q10 deficiencyC Lamperti, A Naini, M Hirano, et al.
Scientific Reports|November 29, 2019
Identification of potential molecular pathogenesis mechanisms modulated by microRNAs in patients with Intestinal Neuronal Dysplasia type BMarcos C Angelini, Alana Maia E Silva, Tainara F Felix, et al.
ESMO Open|May 25, 2023
Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patientsS Giunco, M Padovan, C Angelini, et al.
European Journal of Neurology|February 25, 2009
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutationsR Del Bo, S Ghezzi, S Corti, et al.
Neuromuscular Disorders : NMD|January 1, 1997
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysisG Fouad, M Dalakas, S Servidei, et al.
Human Molecular Genetics|November 1, 1996
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophyE M McNally, D Duggan, J R Gorospe, et al.
European Journal of Neurology|January 31, 2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemiaT Kyriakides, K Aleksovska, C Angelini, et al.
Pageof 54

Showing results (301-310 of 531) with videos related to

Sort By:
Pageof 54
Neuromuscular Disorders : NMD|November 28, 2012
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseasesM Mancuso, C Angelini, E Bertini, et al.
Neurology|August 24, 2005
Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive conditionL Salviati, S Sacconi, L Murer, et al.
Journal of Neurology|July 2, 2010
Right hemisphere dysfunction and emotional processing in ALS: an fMRI studyA Palmieri, M Naccarato, S Abrahams, et al.
Neurology|April 12, 2003
Cerebellar ataxia and coenzyme Q10 deficiencyC Lamperti, A Naini, M Hirano, et al.
Scientific Reports|November 29, 2019
Identification of potential molecular pathogenesis mechanisms modulated by microRNAs in patients with Intestinal Neuronal Dysplasia type BMarcos C Angelini, Alana Maia E Silva, Tainara F Felix, et al.
ESMO Open|May 25, 2023
Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patientsS Giunco, M Padovan, C Angelini, et al.
European Journal of Neurology|February 25, 2009
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutationsR Del Bo, S Ghezzi, S Corti, et al.
Neuromuscular Disorders : NMD|January 1, 1997
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysisG Fouad, M Dalakas, S Servidei, et al.
Human Molecular Genetics|November 1, 1996
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophyE M McNally, D Duggan, J R Gorospe, et al.
European Journal of Neurology|January 31, 2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemiaT Kyriakides, K Aleksovska, C Angelini, et al.
Pageof 54